Bringing Discoveries to Commercialization
ICBI Company Vascugen Licenses Stem Cell Technology for Blood Vessel Regeneration, Raises $635K

Events

ICBI Company Vascugen Licenses Stem Cell Technology for Blood Vessel Regeneration, Raises $635K

Tuesday, May 1, 2018

INDIANAPOLIS, May 1, 2018 — Vascugen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University (IU) School of Medicine related to blood vessel formation from adult stem cells. The regenerative medicine company is focused on finding therapies to repair tissues damaged by reduced blood flow due to disease or injury.

Additionally, Vascugen has also raised around $635 thousand dollars of external funds.

Read more…